Company intelligence / Profile preview
SM Discovery Group
Durham, England, United Kingdomsmdg.org ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
SMDG is an award-winning preclinical-stage biotechnology company developing innovative therapeutic platforms to address neurodegenerative diseases and rare pediatric neurological disorders. Their research emphasizes precision targeting of the blood-brain barrier using engineered peptides for gene therapy and other advanced modalities. No clinical results have been published as of June 2025; the company remains in preclinical development.
- Therapeutic areas
- Neurology
- Modalities
- Gene therapySmall moleculePeptidesDrug delivery devices
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Beyond the preview
Go deeper on SM Discovery Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SM Discovery Group.